It’s become increasingly clear that a lack of diversity in clinical trials is a major issue for the pharmaceutical industry. While the problem has been identified, the industry is still struggling to ...

While challenges remain, AI is accelerating the process by enabling researchers to identify and design new drug candidates more quickly and efficiently with applications in target discovery, structure ...

Data from the Phase III trial program found that AXS-05 demonstrated statistically significant efficacy in treating Alzheimer disease agitation. Axsome Therapeutics announced the successful completion ...

John Hood, CEO, Endeavor BioMedicines discusses a potential timeline on availability of ENV-101 for patients with IPF and further validation of the treatment's safety profile. PE: Given the ...

The FDA has granted Fast Track Designation to Star Therapeutics’ VGA039, an investigational monoclonal antibody targeting Protein S for the treatment of von Willebrand disease (VWD). According to the ...

In the race to bolster pipelines and drive growth, biopharma manufacturers are reexamining traditional practices and reimagining market research protocols. Biopharma business development and licensing ...

The regulatory landscape for CAR T-cell therapies is constantly evolving with the FDA establishing their own guidelines needed for approval. Often, the approval can be long and difficult to obtain.

Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences ...

The FDA has issued a draft guidance outlining recommendations for the use of artificial intelligence (AI) to support regulatory decisions regarding the safety, efficacy, or quality of drugs and ...

Approval was based on results from the Phase III CheckMate-67T trial, which demonstrated non-inferior pharmacokinetics compared to intravenous Opvido. The FDA has approved Bristol Myers Squibb’s (BMS) ...

Why do some creative campaigns succeed while others fail? The answer lies in understanding your audience and how the brain drives decision-making. Neuroscience reveals that subtle cues influence our ...

The pharmaceutical industry continues to experiment with different use cases for AI. While the technology has garnered plenty of headlines over the past two years, the industry has yet to produce a ...